Author: TerryONeal

August 2013 Update from Dr. Henry Klassen

Final preparations are underway to launch the formal pre-clinical studies requested by the FDA as part of the Investigational New Drug (IND) application. Including these pre-clinical studies, the IND application process will require approximately a year to complete. This is the critical

Posted in News, Uncategorized

July 2013 Update from Dr. Henry Klassen

Many people impacted by retinal degenerations, the world over, are eager to hear updates pertaining to our upcoming clinical trial using retinal progenitor cells (RPCs) in RP. The most frequently asked questions specifically relate to the timing and logistics of

Posted in News, Uncategorized

June 2013 Update from Dr. Henry Klassen

In June, Dr. Klassen was invited to attend a special meeting held at the National Institutes of Health (NIH), in Bethesda, MD. The meeting was specifically organized to facilitate the progress into clinical trials of stem cell therapeutics for retinal

Posted in News, Uncategorized

May 2013 Update from Dr. Henry Klassen

A preliminary agreement has been reached with the TRND program at the NIH to collaborate with Dr Klassen’s team on translational development of the novel human retinal progenitor cell approach to treating RP. The annual ARVO meeting was held in

Posted in News, Uncategorized